These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16773407)

  • 1. Transient insulin-dependent diabetes mellitus in children with steroid-dependent idiopathic nephrotic syndrome during tacrolimus treatment.
    Dittrich K; Knerr I; Rascher W; Dötsch J
    Pediatr Nephrol; 2006 Jul; 21(7):958-61. PubMed ID: 16773407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.
    Sinha MD; MacLeod R; Rigby E; Clark AG
    Nephrol Dial Transplant; 2006 Jul; 21(7):1848-54. PubMed ID: 16311257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.
    Wang J; Mao J; Chen J; Fu H; Shen H; Zhu X; Liu A; Shu Q; Du L
    Nephrology (Carlton); 2016 Jan; 21(1):21-7. PubMed ID: 26697959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
    Sinha A; Gupta A; Kalaivani M; Hari P; Dinda AK; Bagga A
    Kidney Int; 2017 Jul; 92(1):248-257. PubMed ID: 28318625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children.
    Gulati S; Prasad N; Sharma RK; Kumar A; Gupta A; Baburaj VP
    Nephrol Dial Transplant; 2008 Mar; 23(3):910-3. PubMed ID: 18039644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
    Gulati A; Sinha A; Gupta A; Kanitkar M; Sreenivas V; Sharma J; Mantan M; Agarwal I; Dinda AK; Hari P; Bagga A
    Kidney Int; 2012 Nov; 82(10):1130-5. PubMed ID: 22763815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus for children with refractory nephrotic syndrome: a one-year prospective, multicenter, and open-label study of Tacrobell®, a generic formula.
    Yang EM; Lee ST; Choi HJ; Cho HY; Lee JH; Kang HG; Park YS; Cheong HI; Ha IS
    World J Pediatr; 2016 Feb; 12(1):60-5. PubMed ID: 26684309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus therapy in adult-onset steroid-resistant nephrotic syndrome due to a focal segmental glomerulosclerosis single-center experience.
    Ramachandran R; Kumar V; Rathi M; Nada R; Jha V; Gupta KL; Sakhuja V; Kohli HS
    Nephrol Dial Transplant; 2014 Oct; 29(10):1918-24. PubMed ID: 24771498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
    Wu B; Mao J; Shen H; Fu H; Wang J; Liu A; Gu W; Shu Q; Du L
    Nephrology (Carlton); 2015 Jan; 20(1):18-24. PubMed ID: 25312783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus in steroid resistant and steroid dependent childhood nephrotic syndrome.
    Supavekin S; Surapaitoolkorn W; Kurupong T; Chaiyapak T; Piyaphanee N; Pattaragarn A; Sumboonnanonda A
    J Med Assoc Thai; 2013 Jan; 96(1):33-40. PubMed ID: 23720975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel multidrug therapy for children with cyclosporine-resistant or -intolerant nephrotic syndrome.
    Aizawa-Yashiro T; Tsuruga K; Watanabe S; Oki E; Ito E; Tanaka H
    Pediatr Nephrol; 2011 Aug; 26(8):1255-61. PubMed ID: 21479767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome.
    Mendizábal S; Zamora I; Berbel O; Sanahuja MJ; Fuentes J; Simon J
    Pediatr Nephrol; 2005 Jul; 20(7):914-9. PubMed ID: 15891923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome.
    Wang W; Xia Y; Mao J; Chen Y; Wang D; Shen H; Fu H; Du L; Liu A
    Pediatr Nephrol; 2012 Nov; 27(11):2073-2079. PubMed ID: 22714672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
    Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases
    Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
    Chen SY; Wu CY; Tsai IJ; Tsau YK
    Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
    Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A plus prednisone treatment of steroid-sensitive frequently relapsing nephrotic syndrome in children.
    Aksu N; Türker M; Erdoğan H; Ozinel S; Kansoy S
    Turk J Pediatr; 1999; 41(2):225-30. PubMed ID: 10770662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.
    Larkins N; Kim S; Craig J; Hodson E
    Arch Dis Child; 2016 Apr; 101(4):404-8. PubMed ID: 26289063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol.
    Hibino S; Uemura O; Nagai T; Yamakawa S; Iwata N; Ito H; Nakano M; Tanaka K
    Pediatr Int; 2015; 57(1):85-91. PubMed ID: 25225083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.